Abstract
We have recently found a novel oncogene, named cancer upregulated gene 2 (CUG2), which activates Ras and mitogen-activated protein kinases (MAPKs), including ERK, JNK and p38 MAPK. Because activation of these signaling pathways has previously been shown to enhance cancer cell susceptibility to oncolysis by certain viruses, we examined whether vesicular stomatitis virus (VSV) could function as a potential therapeutic agent by efficiently inducing cytolysis in cells transformed by CUG2. Unexpectedly, NIH3T3 cells stably expressing CUG2 (NIH-CUG2) were resistant to VSV because of the activation of signal transducers and activators of transcription 1 (STAT1). The result was supported by evidence showing that suppression of STAT1 with short interference RNA (siRNA) renders cells susceptible to VSV. Furthermore, 2′–5′ oligoadenylate synthetase-like (OASL) 2 was the most affected by STAT1 expression level among anti-viral proteins and furthermore suppression of OASL2 mRNA level caused NIH-CUG2 cells to succumb to VSV as seen in NIH-CUG2 cells treated with STAT1 siRNA. In addition, Colon26L5 carcinoma cells stably expressing CUG2 (Colon26L5-CUG2) exhibited resistance to VSV, whereas Colon26L5 stably expressing a control vector yielded to VSV infection. Moreover, Colon26L5-CUG2 cells stably suppressing STAT1 succumbed to VSV infection, resulting in apoptosis. Taken together, we propose that VSV treatment combined with the selective regulation of genes such as STAT1 and OASL2 will improve therapeutic outcomes for CUG2-overexpressing tumors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lee S, Gang J, Jeon SB, Choo SH, Lee B, Kim YG et al. Molecular cloning and functional analysis of a novel oncogene, cancer-upregulated gene 2 (CUG2). Biochem Biophys Res Commun 2007; 360: 633–639.
Kim H, Lee M, Lee S, Park B, Koh W, Lee DJ et al. Cancer-upregulated gene 2 (CUG2), a new component of centromere complex, is required for kinetochore function. Mol Cells 2009; 27: 697–701.
Park EH, Park EH, Cho IR, Srisuttee R, Min HJ, Oh MJ et al. CUG2, a novel oncogene confers reoviral replication through Ras and p38 signaling pathway. Cancer Gene Ther 2010; 17: 307–314.
Rose JK, Whitt MA . Rhabdoviridae: The Viruses and their Replication. In Knipe DM, Howley PM (eds). Field Virology 4th edn Lippincott Williams and Wilkins, New York, 2001: 1221–1244.
de Mattos C, de Mattos CC, Rupprecht CE . Rhabdoviridae: The Viruses and their Replication. In: Knipe DM, Howley PM (eds). Field Virology 4th edn Lippincott Williams and Wilkins: New York, 2001: 1245–1277.
Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 1996; 274: 373–376.
Coffey MC, Strong JE, Forsyth PA, Lee PW . Reovirus therapy of tumors with activated Ras pathway. Science 1998; 282: 1332–1334.
Varghese S, Rabkin SD . Oncolytic herpes simplex virus vectors for cancer virotherapy. Cancer Gene Ther 2002; 9: 967–978.
Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 2000; 6: 821–825.
Fernandez M, Porosnicu M, Markovic D, Barber GN . Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease. J Virol 2002; 76: 895–904.
Leveille S, Samuel S, Goulet ML, Hiscott J . Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy. Cancer Gene Ther 2011; 18: 435–443.
Li Q, Tainsky MA . Epigenetic silencing of IRF7 and/or IRF5 in lung cancer cells leads to increased sensitivity to oncolytic viruses. PLoS One 2011; 6: e28683.
Stephenson KB, Barra NG, Davies E, Ashkar AA, Lichty BD . Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity. Cancer Gene Ther 2012; 19: 238–246.
Porosnicu M, Mian A, Barber GN . The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene. Cancer Res 2003; 63: 8366–8376.
Hovanessian AG . On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2′–5′ oligoadenylate synthetases and the protein kinase PKR. Cytokine Growth Factor Rev 2007; 18: 351–361.
Justesen J, Hartmann R, Kjeldgaard NO . Gene structure and function of the 2'-5'-oligoadenylate synthetase family. Cell Mol Life Sci 2000; 57: 1593–1612.
Skaug B, Chen ZJ . Emerging role of ISG15 in antiviral immunity. Cell 2010; 143: 187–190.
MacMicking JD . IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol 2004; 25: 601–609.
Carter CC, Gorbacheva VY, Vestal DJ . Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain. Arch Virol 2005; 150: 1213–1220.
Liu M, Guo S, Hibbert JM, Jain V, Singh N, Wilson NO et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev 2011; 22: 121–130.
Liu XY, Chen W, Wei B, Shan YF, Wang C . IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1. J Immunol 2011; 187: 2559–2568.
Noser JA, Mael AA, Sakuma R, Ohmine S, Marcato P, Lee PW et al. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells. Mol Ther 2007; 15: 1531–1536.
Battcock SM, Collier TW, Zu D, Hirasawa K . Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. J Virol 2006; 80: 4422–4430.
Ayroldi E, Zollo O, Macchiarulo A, Di Marco B, Marchetti C, Riccardi C . Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol Cell Biol 2002; 22: 7929–7941.
Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods 2001; 25: 402–408.
Christian SL, Collier TW, Zu D, Licursi M, Hough CM, Hirasawa K . Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels. J Virol 2009; 83: 6717–6726.
Ahmed M, Cramer SD, Lyles DS . Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses. Virology 2004; 330: 34–49.
Janelle V, Brassard F, Lapierre P, Lamarre A, Poliquin L . Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy. J Virol 2011; 85: 6513–6520.
Zhang KX, Matsui Y, Hadaschik BA, Lee C, Jia W, Bell JC et al. Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death. Int J Cancer 2010; 127: 830–838.
Ezell SA, Polytarchou C, Hatziapostolou M, Guo A, Sanidas I, Bihani T et al. The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY. Proc Natl Acad Sci USA 2012; 109: E613–E621.
Zhu J, Coyne CB, Sarkar SN . PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and beta-catenin. EMBO J 2011; 30: 4838–4849.
Chun Y, Park B, Koh W, Lee S, Cheon Y, Kim R et al. New centromeric component CENP-W is an RNA-associated nuclear matrix protein that interacts with nucleophosmin/B23 protein. J Biol Chem 2011; 286: 42758–42769.
Okuwaki M . The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein. J Biochem 2008; 143: 441–448.
Grisendi S, Mecucci C, Falini B, Pandolfi PP . Nucleophosmin and cancer. Nat Rev Cancer 2006; 6: 493–505.
Khodarev NN, Roizman B, Weichselbaum RR . Molecular pathways: interferon/stat1 pathway: role in the tumor resistance to genotoxic stress and aggressive growth. Clin Cancer Res 2012; 18: 3015–3021.
Acknowledgements
This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1120140) and the World Class University Program (R31-2008-000-20004-0) through the National Research Foundation funded by the Korean government.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Malilas, W., Koh, S., Srisuttee, R. et al. Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling. Cancer Gene Ther 20, 125–132 (2013). https://doi.org/10.1038/cgt.2012.96
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2012.96
Keywords
This article is cited by
-
Regulatory roles of OASL in lung cancer cell sensitivity to Actinidia chinensis Planch root extract (acRoots)
Cell Biology and Toxicology (2018)
-
Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling
Cellular Oncology (2017)
-
Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model
Gene Therapy (2015)